- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mo | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 2 | GlobeNewswire (USA) | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 24.06. | Picard Medical CEO Patrick NJ Schnegelsberg to depart | 1 | MassDevice | ||
| 24.06. | Picard Medical CEO steps down, board names interim replacement | 2 | Investing.com | ||
| 24.06. | Picard Medical, Inc.: Picard Medical Announces Leadership Transition | 224 | GlobeNewswire (Europe) | TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 24.06. | Picard Medical, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 03.06. | Artificial Heart Maker Picard Medical's Stock Surges 15% After Hours: Here's What's Going On With PMI | 10 | Benzinga.com | ||
| 02.06. | Picard Medical's SynCardia completes milestone study of next-gen total artificial heart | 7 | MassDevice | ||
| 02.06. | Picard Medical, Inc.: Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies | 8 | GlobeNewswire (USA) | ||
| 29.05. | PICARD MEDICAL, INC. Issues Letter to Shareholders | 737 | GlobeNewswire (Europe) | TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and... ► Artikel lesen | |
| 29.05. | Picard Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | Picard Medical reports Q1 results | 1 | Seeking Alpha | ||
| 21.05. | Picard Medical, Inc.: Picard Medical / SynCardia Reports First Quarter 2026 Financial Results | 1 | GlobeNewswire (USA) | ||
| 20.05. | Picard Medical, Inc. - S-1, General form for registration of securities | 3 | SEC Filings | ||
| 15.05. | Picard Medical, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 05.05. | Picard Medical prices $5 million stock offering at $0.30/share | 4 | Investing.com | ||
| 05.05. | Picard Medical platziert Aktienemission über 5 Millionen US-Dollar zu 0,30 US-Dollar je Aktie | 13 | Investing.com Deutsch | ||
| 05.05. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 31,080 | +1,04 % | Truist reiterates Hold on Hims and Hers stock, $23 target on peptide uncertainty | ||
| PLUS THERAPEUTICS | 3,650 | +2,38 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide in Leptomeningeal Metastases Monitoring | HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network (NCCN)... ► Artikel lesen | |
| ORGANON | 11,915 | +0,85 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| QUIDELORTHO | 15,540 | +0,52 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| NANO-X IMAGING | 1,065 | +0,47 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| ROCKWELL MEDICAL | 5,630 | 0,00 % | H.C. Wainwright hebt Kursziel für Rockwell Medical Aktie auf 20 $ an | ||
| NUWELLIS, INC | 3,220 | 0,00 % | XFRA 22S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUWELL.INC.NEW26... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| NEURONETICS | 1,515 | -2,57 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| PULSE BIOSCIENCES | 22,000 | -0,90 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| OPTIMIZERX | 6,530 | 0,00 % | OptimizeRx Corporation: OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,245 | -0,40 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PAVMED | 4,760 | +3,14 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,100 | 0,00 % | CMS-Kehrtwende bei Kostenerstattung: Canaccord bestätigt "Buy"-Rating für Orthofix Medical | ||
| OWLET | 6,445 | +0,55 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo |
PICARD MEDICAL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,148 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PICARD MEDICAL INC finden Sie auf Wallstreet Online.